Dasatrue 50 mg Tablet
  1. Home
  2. Pharma Products
  3. Cipla Ltd
  4. Dasatrue 50 mg Tablet

Dasatrue 50 mg Tablet

Dasatrue 50 mg Tablet contains dasatinib 50 mg, a targeted anticancer medicine used for certain blood cancers. It is an oral tablet taken according to the treatment plan prescribed by the oncologist. Dasatinib blocks abnormal tyrosine kinase proteins that promote the growth of leukemia cells.

BUY NOW

Category

Dasatrue 50 mg Tablet is used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Dasatinib belongs to the tyrosine kinase inhibitor class and works by interfering with proteins involved in abnormal cancer-cell growth and survival. The dosage and treatment duration are determined by the treating oncologist according to the patient’s condition and response to therapy. Regular blood tests and medical follow-up may be required during treatment.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 50 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 60 Tablets
Manufacturer Cipla Ltd

Product Also Known As

Dasatrue 50 mg Tablet, Dasatrue 50 Tablet, Dasatrue Dasatinib Tablet, Dasatinib 50 mg Tablet, Dasatinib Leukemia Tablet, Dasatinib Tyrosine Kinase Inhibitor Tablet